Rss page https://www.lareb.nl/en/ The latest news and headlines from Centrum lareb. en-US Copyright 2026 11092 Florence van Hunsel appointed as Professor of Pharmacovigilance Dr. Florence van Hunsel, pharmacist and senior epidemiologist at the Netherlands Pharmacovigilance Centre Lareb, becomes Professor by special appointment of Pharmacovigilance at th... Mon, 10 Nov 2025 13:00:25 G11T https://www.lareb.nl/en/news/florence-van-hunsel-appointed-as-professor-of-pharmacovigilance/ 11031 More reports of liver toxicity with Ashwagandha In September 2023, the Netherlands Pharmacovigilance centre Lareb warned of liver toxicity in people using products containing ashwagandha. Since then, Lareb has received eight new... Wed, 09 Jul 2025 14:48:41 G7T https://www.lareb.nl/en/news/more-reports-of-liver-toxicity-with-ashwagandha/ 10986 Illegal addition of medication to herbal supplement Montalin once again Users of the herbal supplement Montalin may unknowingly ingest a corticosteroid. This can lead to unintended and potentially serious consequences. The Dutch Pharmacovigilance Centr... Mon, 24 Mar 2025 13:12:25 G3T https://www.lareb.nl/en/news/illegal-addition-of-medication-to-herbal-supplement-montalin-once-again/ 8967 COVID-19 vaccination during pregnancy and neonatal health Using data from the Dutch Pregnancy Drug Register, Netherlands Pharmacovigilance Centre Lareb found no association between COVID-19 vaccination during pregnancy and the neonatal he... J07BX Thu, 14 Nov 2024 12:52:47 G11T https://www.lareb.nl/en/news/covid-19-vaccination-during-pregnancy-and-neonatal-health/ 8965 Nerve damage due to the use of nutritional supplements with vitamin B6 The Netherlands Pharmacovigilance Centre Lareb has previously reported on nerve damage caused by the use of nutritional supplements containing vitamin B6. These reports are still b... Wed, 13 Nov 2024 11:23:49 G11T https://www.lareb.nl/en/news/nerve-damage-due-to-the-use-of-nutritional-supplements-with-vitamin-b6/ 8958 MedSafetyWeek 2024 Today, the MedSafetyWeek starts. The MedSafetyWeek is an annual (social) media campaign focussing on raising awareness of pharmacovigilance, and promoting recognition and reporting... Mon, 04 Nov 2024 08:00:00 G11T https://www.lareb.nl/en/news/medsafetyweek-2024/ 8955 Fever and mebendazole Until July 2024, the Netherlands Pharmacovigilance Centre Lareb received 23 reports of fever following use of mebendazole. Fever is not a known side effect of mebendazole. Fever is... P02CA01 Thu, 24 Oct 2024 10:26:56 G10T https://www.lareb.nl/en/news/fever-and-mebendazole/ 7950 Highlighting challenges in monitoring herbal products and presenting universal recommendations Lareb conducted a study comprised of semi-structured interviews in order to explore the current landscape of herbal pharmacovigilance and to offer recommendations for best practice... Wed, 18 Sep 2024 16:02:29 G9T https://www.lareb.nl/en/news/highlighting-challenges-in-monitoring-herbal-products-and-presenting-universal-recommendations/ 6915 Prolonged duration of COVID-19 vaccine-induced lymphadenopathy The Netherlands Pharmacovigilance Centre Lareb has received reports of enlarged lymph nodes after COVID-19 vaccination that do not disappear within the expected 1 to 2 weeks. In so... j07bn Thu, 27 Jun 2024 13:05:54 G6T https://www.lareb.nl/en/news/prolonged-duration-of-covid-19-vaccine-induced-lymphadenopathy/ 6893 Possible ischaemic colitis after bisacodyl use The Netherlands Pharmacovigilance Centre Lareb received two reports of ischaemic colitis after bisacodyl use. Ischaemic colitis often resolves spontaneously, but colonic surgery is... A06AB02 Thu, 30 May 2024 14:41:53 G5T https://www.lareb.nl/en/news/possible-ischaemic-colitis-after-bisacodyl-use/